Research Article

Development and Validation of Stability-Indicating RP-UPLC Method for the Determination of Methdilazine in Bulk Drug and in Pharmaceutical Dosage Form

Table 1

Summary of solvent optimization.

Solvent ASolvent BObservations/remarks

5 mM ammonium acetateMethanolVery broad peak with peak splitting
5 mM ammonium acetateAcetonitrilePeak eluted too early
Dibasic potassium phosphate (pH 3.0 with 10% H3PO4)MethanolVery broad peak with peak splitting
Dibasic potassium phosphate (pH 3.0 with 10% H3PO4)AcetonitrileLess theoretical plates and peak fronting
Monobasic potassium phosphate (pH 3.0 with 10% H3PO4)MethanolBroad peak and less theoretical plates
Potassium dihydrogen orthophosphate and 1-pentane sulphonic acid (pH 4.0) at 60% ratioAcetonitrile at 40% ratioGood peak shape with theoretical plates above 2000